We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EFPIA Seeks More Efficient Pathway for Drugs for Unmet Needs
EFPIA Seeks More Efficient Pathway for Drugs for Unmet Needs
European drugmakers are pressing regulators to streamline the conditional marketing authorization pathway for drugs that fulfill unmet needs, saying the current system is slower than the standard authorization process.